Economic Burden of Colorectal Cancer in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.
Abstract
Objectives: The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service. Methods: Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs. Results: The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively. Conclusions: Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.
참고문헌 (30)
- Annual report of cancer statistics in Korea in 2010, "Ministry of Health and Welfare", Ministry of Health and Welfare, 10~21 (2010)
- "Causes of death statistics in 2012: incidence and mortality of cancer"[URL]
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62(1), pp.10~29 (2012)
- Azrak MF, "Essentials of gastroenterology", pp.132~146 (2012), Wiley-Blackwell
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009", Cancer Research and Treatment, 44(1), pp.11~24 (2012), 대한암학회
- Ministry of Health and Welfare, "Cancer facts and figures", Ministry of Health and Welfare, 13~16 (2010)
- "Colorectal cancer incidence: mortality and prevalence worldwide in 2008 summary"[URL]
- 이보인, "Korean Guidelines for Colorectal Cancer Screening and Polyp Detection", Clinical Endoscopy, 45(1), pp.25~43 (2012), 대한소화기내시경학회[DOI]
- Kim SG, "The economic burden of cancer in Korea in 2002", Eur J Cancer Care (Engl), 17(2), pp.136~144 (2008)
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- "Cost-of-illness studies: a primer; 2006"[URL]
- "ICD-10 International Statistical Classification of Diseases and related health problems: 10th revision"[URL]
- Benson AB 3rd, "Epidemiology, disease progression, and economic burden of colorectal cancer", J Manag Care Pharm, 13(6 Suppl C), pp.S5~S18 (2007)
- Hornbrook MC, "Outcomes assessment in cancer", pp.480~502 (2005), Cambridge University Press
- Health Insurance Patients Payments Survey, "Park M", Health Insurance Corporation, 15~ (2011)
- A report on the Korea Health Panel Survey of 2008, "Jung YH", Korea Institute for Health and Social Affairs, 38~ (2010)
- "Nursing pay guide"[URL]
- "Consumer Price Survey (index) guide; 2010"[URL]
- Cartwright WS, "Methods for the economic evaluation of health care programmes" (1997), Oxford University Press
- "Survey on the structure of wages by the Ministry of Labor in Korea; 2007"[URL]
- Kim SG, "The economic burden of cancer in Korea in 2002", Eur J Cancer Care, 17(2), pp.136~144 (2008)
- 조희숙, "일차의료의 발전방안", 대한의사협회지, 55(10), pp.959~968 (2012), 대한의사협회
- "Korean national health accounts and total health expenditure; 2010"[URL]
- Myong JP, "Factors associated with participation in colorectal cancer screening in Korea: the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)", Int J Colorectal Dis, 27(8), pp.1061~1069 (2012)
- 신정임, "Results of Colorectal Cancer Screening of the National Cancer Screening Program in Korea, 2008", Cancer Research and Treatment, 42(4), pp.191~198 (2010), 대한암학회
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2013", Cancer Research and Treatment, 45(1), pp.15~21 (2013), 대한암학회[DOI]
- Fautrel B, "Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method", Med Decis Making, 27(2), pp.138~150 (2007)
- Martin-Moreno JM, "Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis", Eur J Cancer, 48(14), pp.2212~2218 (2012)
- Ferrante JM, "Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries", Arch Intern Med, 171(19), pp.1747~1757 (2011)
- Martinez ME, "Tumor prevention and genetics III", pp.177~211 (2005), Springer